Journal article icon

Journal article

5q- syndrome.

Abstract:

In recent years we have gained great insight into the molecular pathogenesis of the 5q- syndrome, the most distinct of all the myelodysplastic syndromes. It is now recognized that p53 activation, caused by haploinsufficiency for the ribosomal gene RPS14 (mapping to the commonly deleted region), is the probable cause of the erythroid defect in the 5q- syndrome. A mouse model of the human 5q- syndrome has been generated by large-scale deletion of the Cd74-Nid67 interval (containing Rps14) and t...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.2174/1381612811209023180

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, Clinical Lab Sciences, Biomedical Research Centre
Role:
Author
Journal:
Current pharmaceutical design
Volume:
18
Issue:
22
Pages:
3180-3183
Publication date:
2012-01-01
DOI:
EISSN:
1873-4286
ISSN:
1381-6128
URN:
uuid:92bccc99-6cfa-48a8-b591-1190287447a6
Source identifiers:
329109
Local pid:
pubs:329109

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP